Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Has Average Target Price of $21.67 According to Brokerages

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been given a consensus recommendation of “Moderate Buy” by the fourteen brokerages that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $21.67.

A number of equities analysts have weighed in on the company. Wells Fargo & Company reduced their price objective on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating for the company in a research note on Monday, October 19th. Citigroup reiterated a “market outperform” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Deutsche Bank reissued a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Huntington assumed coverage on shares of Sabra Healthcare REIT in a research note on Monday, November 2nd. They set a “strong-buy” rating on the stock. Finally, Barclays dropped their price target on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Tuesday, October 13th.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ SBRA opened at $20.44 on Friday. Sabra Healthcare REIT has a 52 week low of $17.53 and a 52 week high of $22.77. The business’s 50 day moving average price is $19.88 and its 200 day moving average price is $20.04. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.86. The firm has a market cap of $5.35 billion, a P/E ratio of 73.00, a P/E/G ratio of 1.79 and a beta of 0.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). The business had revenue of $249.57 million for the quarter, compared to analysts’ expectations of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. The company’s revenue for the quarter was up 31.4% on a year-over-year basis. During the same period last year, the business earned $0.38 EPS. On average, sell-side analysts expect that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Friday, November 13th. Sabra Healthcare REIT’s dividend payout ratio is presently 428.57%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard K. Matros sold 200,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the transaction, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Foster sold 10,000 shares of the stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total value of $209,800.00. Following the transaction, the director owned 72,834 shares in the company, valued at $1,528,057.32. This represents a 12.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.09% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Versant Capital Management Inc lifted its position in shares of Sabra Healthcare REIT by 70.0% during the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 603 shares in the last quarter. Root Financial Partners LLC purchased a new stake in Sabra Healthcare REIT in the 3rd quarter worth $34,000. Heritage Family Offices LLP acquired a new position in Sabra Healthcare REIT during the third quarter worth $45,000. Mather Group LLC. raised its position in Sabra Healthcare REIT by 34,550.0% during the third quarter. Mather Group LLC. now owns 2,772 shares of the real estate investment trust’s stock worth $55,000 after acquiring an additional 2,764 shares during the period. Finally, Integrated Wealth Concepts LLC acquired a new position in Sabra Healthcare REIT during the second quarter worth $61,000. 99.40% of the stock is owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.